Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse

[1] Arribas J(2006)ADAMs, cell migration and cancer Cancer Metastasis Rev 25 57-68

[2] Bech-Serra JJ(2006)Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis Mol Cell Biol 26 5086-5095

[3] Santiago-Josefat B(2006)Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer J Clin Pathol 59 403-409

[4] Bech-Serra JJ(2000)Activated leukocyte cell adhesion molecule (ALCAM) and annexin II are involved in the metastatic progression of tumor cells after chemotherapy with Adriamycin Clin Exp Metastasis 18 45-50

[5] Santiago-Josefat B(1996)Significance of lymph node metastases in patients with pancreatic cancer undergoing curative resection Am J Surg 172 463-468

[6] Esselens C(2008)Most pancreatic cancer resections are R1 resections Ann Surg Oncol 15 1651-1660

[7] Saftig P(1993)Prognostic indicators for survival after resection of pancreatic adenocarcinoma Am J Surg 165 68-72

[8] Baselga J(2008)The impact of lymph node number on survival in patients with lymph node-negative pancreatic cancer Pancreas 37 19-24

[9] Arribas J(2008)Cancer statistics, 2008 CA Cancer J Clin 58 71-96

[10] Canals F(2006)ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy Med Sci Monit 12 BR263-BR273

[1] Arribas J(2006)ADAMs, cell migration and cancer Cancer Metastasis Rev 25 57-68

[2] Bech-Serra JJ(2006)Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis Mol Cell Biol 26 5086-5095

[3] Santiago-Josefat B(2006)Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer J Clin Pathol 59 403-409

[4] Bech-Serra JJ(2000)Activated leukocyte cell adhesion molecule (ALCAM) and annexin II are involved in the metastatic progression of tumor cells after chemotherapy with Adriamycin Clin Exp Metastasis 18 45-50

[5] Santiago-Josefat B(1996)Significance of lymph node metastases in patients with pancreatic cancer undergoing curative resection Am J Surg 172 463-468

[6] Esselens C(2008)Most pancreatic cancer resections are R1 resections Ann Surg Oncol 15 1651-1660

[7] Saftig P(1993)Prognostic indicators for survival after resection of pancreatic adenocarcinoma Am J Surg 165 68-72

[8] Baselga J(2008)The impact of lymph node number on survival in patients with lymph node-negative pancreatic cancer Pancreas 37 19-24

[9] Arribas J(2008)Cancer statistics, 2008 CA Cancer J Clin 58 71-96

[10] Canals F(2006)ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy Med Sci Monit 12 BR263-BR273